2003
DOI: 10.1016/s1383-5769(03)00012-6
|View full text |Cite
|
Sign up to set email alerts
|

The efficacy of ascofuranone in a consecutive treatment on Trypanosoma brucei brucei in mice

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1

Citation Types

1
57
0

Year Published

2004
2004
2019
2019

Publication Types

Select...
5
2
1

Relationship

2
6

Authors

Journals

citations
Cited by 78 publications
(60 citation statements)
references
References 38 publications
1
57
0
Order By: Relevance
“…Indeed, we have previously reported that the antibiotic ascofuranone (AF), isolated from the pathogenic fungus Ascochyta viciae, specifically inhibits the quinol oxidase activity of TAO at subnanomolar concentrations and rapidly kills the parasites (10). Furthermore, we have confirmed the chemotherapeutic efficacy of ascofuranone in vivo (11,12).…”
mentioning
confidence: 59%
“…Indeed, we have previously reported that the antibiotic ascofuranone (AF), isolated from the pathogenic fungus Ascochyta viciae, specifically inhibits the quinol oxidase activity of TAO at subnanomolar concentrations and rapidly kills the parasites (10). Furthermore, we have confirmed the chemotherapeutic efficacy of ascofuranone in vivo (11,12).…”
mentioning
confidence: 59%
“…Due to the reliance of bloodstream-form African trypanosomes on glycolysis, coupled to the glycerol-3-phosphate oxidation required to regenerate NAD + , TAO has been proposed to be a candidate drug target (Yabu et al 2003 ;Chaudhuri et al 2006). However, computer modelling of metabolic flux and RNAi-mediated depletion of TAO suggests, in vitro, that the TAO protein would have to be inhibited by more than 95 % for there to be a significant effect on trypanosome growth (Helfert et al 2001).…”
Section: Trypanosome Alternative Oxidase (Tao)mentioning
confidence: 99%
“…However, computer modelling of metabolic flux and RNAi-mediated depletion of TAO suggests, in vitro, that the TAO protein would have to be inhibited by more than 95 % for there to be a significant effect on trypanosome growth (Helfert et al 2001). In T. brucei, TAO inhibition is only lethal when coupled with administration of glycerol to block glycerol-phosphate dehydrogenase or with repeated administration of the inhibitor (Yabu et al 1998(Yabu et al , 2003. Nevertheless, the demonstration that inhibitor treatment can cure mice suggests that the TAO may be a viable drug target.…”
Section: Trypanosome Alternative Oxidase (Tao)mentioning
confidence: 99%
“…In this respect it is interesting to note that ascofuranone, isolated from the pathogenic fungus Ascochyta visiae, specifically and potently inhibits the quinol oxidase activity of TAO (11) and rapidly kills the parasites. In addition, the chemotherapeutic efficacy of ascofuranone in vivo has been confirmed (12).…”
mentioning
confidence: 90%